If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

  • There is currently no data for SNG

Synairgen News

AIM WINNERS & LOSERS: Solid State order win; Synairgen plots AIM exit
11 Mar 2025

AIM WINNERS & LOSERS: Solid State order win; Synairgen plots AIM exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

AIM WINNERS & LOSERS: Tiger Royalties to buy Bixby Technologies
20 Dec 2024

AIM WINNERS & LOSERS: Tiger Royalties to buy Bixby Technologies

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

EARNINGS: Hansard Global profit down; Flowtech cuts outlook
26 Sep 2024

EARNINGS: Hansard Global profit down; Flowtech cuts outlook

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...

IN BRIEF: Synairgen slashes costs and focuses on small hospital trials
27 Jun 2024

IN BRIEF: Synairgen slashes costs and focuses on small hospital trials

Synairgen PLC - South Hampton, England-based drug discovery and development company focused on combatting respiratory disease - In 2023, pretax loss n...

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
7 May 2024

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO
11 Oct 2023

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints ...

Synairgen names Joseph Colliver as CFO
11 Oct 2023

Synairgen names Joseph Colliver as CFO

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.